These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36001969)

  • 1. The AMPK-HOXB9-KRAS axis regulates lung adenocarcinoma growth in response to cellular energy alterations.
    Wang T; Guo H; Li Q; Wu W; Yu M; Zhang L; Li C; Song J; Wang Z; Zhang J; Tang Y; Kang L; Zhang H; Zhan J
    Cell Rep; 2022 Aug; 40(8):111210. PubMed ID: 36001969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitor of Differentiation-1 Sustains Mutant
    Román M; López I; Guruceaga E; Baraibar I; Ecay M; Collantes M; Nadal E; Vallejo A; Cadenas S; Miguel ME; Jang JH; Martin-Uriz PS; Castro-Labrador L; Vilas-Zornoza A; Lara-Astiaso D; Ponz-Sarvise M; Rolfo C; Santos ES; Raez LE; Taverna S; Behrens C; Weder W; Wistuba II; Vicent S; Gil-Bazo I
    Cancer Res; 2019 Feb; 79(3):625-638. PubMed ID: 30563891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of CTHRC1 by HOXB9 Promotes Angiogenesis through Fatty Acid Metabolism in Lung Adenocarcinoma.
    Liu K; Li X; Yang Z; Zhang R
    Rev Invest Clin; 2022; 75(2):63-75. PubMed ID: 37205792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis.
    Ding K; Jiang X; Wang Z; Zou L; Cui J; Li X; Shu C; Li A; Zhou J
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YTHDF1 Promotes Cyclin B1 Translation through m
    Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation.
    Yin H; Wang Z; Wang D; Nuer M; Han M; Ren P; Ma S; Lin C; Chen J; Xian H; Ai D; Li X; Ma S; Lin Z; Pan Y
    Eur J Pharmacol; 2023 Sep; 955():175883. PubMed ID: 37433364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of
    Kim S; Kim J; Jung Y; Jun Y; Jung Y; Lee HY; Keum J; Park BJ; Lee J; Kim J; Lee S; Kim J
    Mol Cells; 2020 Jul; 43(7):619-631. PubMed ID: 32638704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.
    Wan J; Xu W; Zhan J; Ma J; Li X; Xie Y; Wang J; Zhu WG; Luo J; Zhang H
    Nucleic Acids Res; 2016 Dec; 44(22):10662-10675. PubMed ID: 27613418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alveolar type I cells can give rise to KRAS-induced lung adenocarcinoma.
    Yang M; Shen H; Flodby P; Koss MD; Bassiouni R; Liu Y; Jashashvili T; Neely A; Ogbolu E; Castillo J; Stueve TR; Mullen DJ; Ryan AL; Carpten J; Castaldi A; Wallace WD; Zhou B; Borok Z; Marconett CN
    Cell Rep; 2023 Dec; 42(12):113286. PubMed ID: 37995179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.
    Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H
    Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of AMPK Leads to Attenuation of Antigen Presentation and Immune Evasion in Lung Adenocarcinoma.
    Gao Y; Päivinen P; Tripathi S; Domènech-Moreno E; Wong IPL; Vaahtomeri K; Nagaraj AS; Talwelkar SS; Foretz M; Verschuren EW; Viollet B; Yan Y; Mäkelä TP
    Clin Cancer Res; 2022 Jan; 28(1):227-237. PubMed ID: 34667030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinoma.
    Zhan J; Wang P; Niu M; Wang Y; Zhu X; Guo Y; Zhang H
    Histopathology; 2015 Jun; 66(7):955-65. PubMed ID: 25324169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma.
    Hu K; Li K; Lv J; Feng J; Chen J; Wu H; Cheng F; Jiang W; Wang J; Pei H; Chiao PJ; Cai Z; Chen Y; Liu M; Pang X
    J Clin Invest; 2020 Apr; 130(4):1752-1766. PubMed ID: 31874110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.
    Nokin MJ; Darbo E; Travert C; Drogat B; Lacouture A; San José S; Cabrera N; Turcq B; Prouzet-Mauleon V; Falcone M; Villanueva A; Wang H; Herfs M; Mosteiro M; Jänne PA; Pujol JL; Maraver A; Barbacid M; Nadal E; Santamaría D; Ambrogio C
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-stage lung cancer is driven by a transitional cell state dependent on a KRAS-ITGA3-SRC axis.
    Moye AL; Dost AF; Ietswaart R; Sengupta S; Ya V; Aluya C; Fahey CG; Louie SM; Paschini M; Kim CF
    EMBO J; 2024 Jul; 43(14):2843-2861. PubMed ID: 38755258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS-mutated lung adenocarcinoma.
    Li HS; Liu CM; Wang Y
    Thorac Cancer; 2023 May; 14(15):1368-1382. PubMed ID: 37021520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPKα loss promotes KRAS-mediated lung tumorigenesis.
    La Montagna M; Shi L; Magee P; Sahoo S; Fassan M; Garofalo M
    Cell Death Differ; 2021 Sep; 28(9):2673-2689. PubMed ID: 34040167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.
    Dai D; Shi R; Han S; Jin H; Wang X
    Medicine (Baltimore); 2020 Aug; 99(32):e21478. PubMed ID: 32769881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinase PLK1 promotes the development of
    Kong Y; Allison DB; Zhang Q; He D; Li Y; Mao F; Li C; Li Z; Zhang Y; Wang J; Wang C; Brainson CF; Liu X
    Sci Signal; 2022 Oct; 15(754):eabj4009. PubMed ID: 36194647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.